| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/06/2012 | US20120309010 Detection of nucleic acids and proteins |
| 12/06/2012 | US20120309007 Prostate cancer prognostic compositions and kits |
| 12/06/2012 | US20120308997 Spatially resolved ligand-receptor binding assays |
| 12/06/2012 | US20120308994 Slpa as a tool for recombinant protein and enzyme technology |
| 12/06/2012 | US20120308597 Serologic correlates of protection against bacillis anthracis infection |
| 12/06/2012 | US20120308580 Hepatitus b virus specific antibody and usese thereof |
| 12/06/2012 | US20120308578 SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES |
| 12/06/2012 | US20120308576 Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands |
| 12/06/2012 | US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
| 12/06/2012 | US20120308572 Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies |
| 12/06/2012 | US20120308570 Methods for treating diseases |
| 12/06/2012 | US20120308569 Gene products differentially expressed in cancerous cells |
| 12/06/2012 | US20120308534 Neural progenitor cell populations |
| 12/06/2012 | US20120308521 Compositions and Methods for Treatment of Cancer Using Tissue-Specific Oncolytic Adenoviruses |
| 12/06/2012 | US20120308513 Promiscuous her-2/neu cd4 t cell epitopes |
| 12/06/2012 | US20120308482 Monkey Homolog of Human Interferon Omega |
| 12/06/2012 | US20120308479 Brain Endothelial Cell Expression Patterns |
| 12/06/2012 | US20120308436 Analysis system of biological particles in liquid flow |
| 12/06/2012 | US20120308435 System, apparatus, and method for closed tube sampling and open tube sampling for automated clinical analyzers |
| 12/06/2012 | US20120307969 Testing device for determining the quality of leather |
| 12/06/2012 | US20120307245 Device and method for investigating analytes in liquid suspension or solution |
| 12/06/2012 | US20120305409 Apparatus and Methods for Analyte Measurement and Immunoassay |
| 12/06/2012 | US20120305396 Electrochemical Cell and Method of Making an Electrochemical Cell |
| 12/06/2012 | US20120305395 Device for the Determination of Glycated Hemoglobin |
| 12/06/2012 | US20120305264 Solvent Surveillance in Solvent-Based Heavy Oil Recovery Processes |
| 12/06/2012 | US20120304763 Optical method and apparatus for determining a characteristic such as volume and density of an excavated void in a construction material |
| 12/06/2012 | US20120304744 Urea quality diagnosis system |
| 12/06/2012 | US20120304734 In-oil gas concentration measuring system and in-oil gas concentration measuring method using same system |
| 12/06/2012 | US20120304730 Methods, systems, and apparatus for generating a gas stream having a desired particulate material concentration |
| 12/06/2012 | US20120304715 Status Monitoring System for a Fenestration Unit |
| 12/06/2012 | DE112011100765T5 Kalibriervorrichtung für Online-Schwefelhexafluorid-Feuchtigkeitsmessgeräte und ihr Kalibrierverfahren Calibration device for on-line sulfur hexafluoride moisture measuring instruments and their calibration |
| 12/06/2012 | DE10217543B4 Verfahren zur spektrometrischen Bestimmung der Sauerstoffsättigung von Blut in Gegenwart optischer Störgrößen A method for spectrophotometric determination of the oxygen saturation of blood in the presence of optical interference |
| 12/06/2012 | DE102012009379A1 Method for determining risk of corrosion of components of prototype vehicle, involves calculating risk factors associated with general basic condition, constructional corrosion protection and corrosion protection measure features |
| 12/06/2012 | DE102011103950A1 Device for detecting and removing harmful tissue, has control and evaluating device that evaluates detector signals and controls laser beam source depending on result of evaluation of detector signals |
| 12/06/2012 | DE102011076677A1 Spektroskopische Messeinrichtung Spectroscopic measurement device |
| 12/06/2012 | DE102011001952B4 Vorrichtung und Verfahren zur Bestimmung der Koagulationszeit von Blut Apparatus and method for determining the coagulation time of blood |
| 12/06/2012 | DE102009040879B4 Verfahren zur Bestimmung der Gerinnungszeit A method for determining the clotting time |
| 12/06/2012 | DE102007033124B4 Vorrichtung zur optischen Detektion von Substanzen in einem flüssigen oder gasförmigen Medium Device for the optical detection of substances in a liquid or gaseous medium, |
| 12/06/2012 | CA2856798A1 Detection of degradation products of feline nt-probnp |
| 12/06/2012 | CA2843470A1 Brain tumor targeting peptides and methods |
| 12/06/2012 | CA2838086A1 Molecular diagnostic test for cancer |
| 12/06/2012 | CA2838053A1 Methods and compositions for detecting endometrial or ovarian cancer |
| 12/06/2012 | CA2837852A1 Biomarkers for hedgehog inhibitor therapy |
| 12/06/2012 | CA2837598A1 Method for assessment of hepatic function and portal blood flow |
| 12/06/2012 | CA2837546A1 Dsrna/dna hybrid genome replication intermediate of metakaryotic stem cells |
| 12/06/2012 | CA2837527A1 Fc receptor binding proteins |
| 12/06/2012 | CA2837518A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection |
| 12/06/2012 | CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies |
| 12/06/2012 | CA2837463A1 High-speed screening apparatus for a raman analysis-based high-speed multiple drug |
| 12/06/2012 | CA2837331A1 Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling |
| 12/06/2012 | CA2837306A1 Coupling method |
| 12/06/2012 | CA2837153A1 Method for detecting and quantifying a target molecule in a tissue |
| 12/06/2012 | CA2837041A1 Capillary fluid flow measurment and capillary flow device therefore |
| 12/06/2012 | CA2836947A1 Anti-emr1 antibodies |
| 12/06/2012 | CA2836608A1 Microfluidic cell trap and assay apparatus for high-throughput analysis |
| 12/06/2012 | CA2836490A1 Method of assessing risk of pml |
| 12/06/2012 | CA2836236A1 Tsh immunoassays and processes for performing tsh immunoassays in the presence of endogenous contaminants in restricted wash formats |
| 12/06/2012 | CA2834455A1 Methods for diagnosing multiple sclerosis |
| 12/05/2012 | EP2530701A2 Quantitative peptide analysis by mass spectrometry |
| 12/05/2012 | EP2530468A1 HUMAN sCD14-ST ASSAY METHOD |
| 12/05/2012 | EP2530466A1 Method and device for trichomonas detection |
| 12/05/2012 | EP2530465A1 Method for immunoassay of autoantibody against ku86, kit for use in same, and method for determination of primary hepatocellular carcinoma using same |
| 12/05/2012 | EP2530464A1 Amyloid measurement method |
| 12/05/2012 | EP2530463A1 Indicator for determining the state of skin |
| 12/05/2012 | EP2530462A1 Methods and kits for predicting tumor responses to antibodies against epidermal growth factor receptor (EGFR) and uses thereof |
| 12/05/2012 | EP2530458A1 Method and device for measuring basis weight and water content amount |
| 12/05/2012 | EP2530091A1 Anti-dll3 antibody |
| 12/05/2012 | EP2530087A2 Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof |
| 12/05/2012 | EP2530055A1 System and method of controlling dosing of a disinfectant into water |
| 12/05/2012 | EP2529238A2 Hanging drop devices, systems and/or methods |
| 12/05/2012 | EP2529236A2 Rotationally actuated magnetic bead trap and mixer |
| 12/05/2012 | EP2529235A2 Means and methods for diagnosing heart failure in a subject |
| 12/05/2012 | EP2529234A1 Method for determination of aggregates |
| 12/05/2012 | EP2529233A2 Mass spectrometry-based protein identification |
| 12/05/2012 | EP2529232A1 Rapid characterization of proteins in complex biological fluids |
| 12/05/2012 | EP2529231A1 Biomarkers |
| 12/05/2012 | EP2529230A2 Biomarkers |
| 12/05/2012 | EP2529229A1 Diagnosing prostate cancer relapse |
| 12/05/2012 | EP2529228A1 Method of determination of autoantibody level by means of enzyme immunoassay |
| 12/05/2012 | EP2529227A1 Cytomegalovirus-based immunogenic preparations |
| 12/05/2012 | EP2529226A1 Silylated biomolecules |
| 12/05/2012 | EP2529225A1 Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors |
| 12/05/2012 | EP2529224A1 Sampling and testing device for the human or animal body |
| 12/05/2012 | EP2529223A1 Biomarkers for circulating tumor cells |
| 12/05/2012 | EP2529222A2 Multiple biomarker panels to stratify disease severity and monitor treatment of depression |
| 12/05/2012 | EP2529221A1 Thrombin generation determination method |
| 12/05/2012 | EP2529220A2 Centrifugal micro-fluidic device and method for detecting analytes from liquid specimen |
| 12/05/2012 | EP2529219A1 Electrode arrangements for biosensors |
| 12/05/2012 | EP2529218A1 Self-metering system and testing device with casing and sliding member to cut-off and set sample volume |
| 12/05/2012 | EP2529217A1 On-line system, method of its calibration and simultaneous detection of antibiotic residues and their concentration in milk |
| 12/05/2012 | EP2529204A2 Gemstone sparkle analysis |
| 12/05/2012 | EP2529202A1 Device, system and method for quantifying fluorescence and optical properties |
| 12/05/2012 | EP2529201A1 Photoluminescent pressure probe |
| 12/05/2012 | EP2529199A1 Measuring system and measuring method, in particular for determining blood glucose |
| 12/05/2012 | EP2529195A1 Method for in vitro detection of ataxia telangiectasia healthy carriers and related kit |
| 12/05/2012 | EP2529194A2 Systems and methods for collecting and depositing particulate matter onto tissue samples |
| 12/05/2012 | EP2529033A1 Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders |
| 12/05/2012 | EP2529016A1 Methods and compositions using fgf23 fusion polypeptides |
| 12/05/2012 | EP2528948A2 Novel lowered affinity antibodies and methods of marking the same |
| 12/05/2012 | EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |